Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of RNA modification in hepatocellular carcinoma
Qiang Feng, Dongxu Wang, Tianyi Xue, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20

Showing 20 citing articles:

Epitranscriptome: Review of Top 25 Most-Studied RNA Modifications
Viktoriia A. Arzumanian, Georgii Dolgalev, Ilya Y. Kurbatov, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13851-13851
Open Access | Times Cited: 45
Mapping epigenetic modifications by sequencing technologies
Xiufei Chen, Haiqi Xu, Xiao Ou Shu, et al.
Cell Death and Differentiation (2023)
Open Access | Times Cited: 37
M7G-related tumor immunity: novel insights of RNA modification and potential therapeutic targets
Mengzhen Han, Qibo Huang, Xinxin Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 4, pp. 1238-1255
Open Access | Times Cited: 8
Photosensitive and dual-targeted chromium nanoparticle delivering small interfering RNA YTHDF1 for molecular-targeted immunotherapy in liver cancer
Shang Chen, Yan He, Xin Huang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Pseudouridine synthase 1 promotes hepatocellular carcinoma through mRNA pseudouridylation to enhance the translation of oncogenic mRNAs
Yanxia Hu, Li‐Ting Diao, Ya‐Rui Hou, et al.
Hepatology (2023) Vol. 80, Iss. 5, pp. 1058-1073
Closed Access | Times Cited: 11
RNA modifications in the progression of liver diseases: from fatty liver to cancer
Simiao Li‐Sauerwine, Wajahat Z. Mehal, Xinshou Ouyang
Science China Life Sciences (2024) Vol. 67, Iss. 10, pp. 2105-2119
Open Access | Times Cited: 4
m6A epitranscriptomic modification in hepatocellular carcinoma: implications for the tumor microenvironment and immunotherapy
Yong Li, Qingbin Liu, Xianying Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The impact of epitranscriptomic modifications on liver disease
Keith A. Berggren, Robert E. Schwartz, Ralph E. Kleiner, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 4, pp. 331-346
Closed Access | Times Cited: 3
Cross-Regulation Between Redox and Epigenetic Systems in Tumorigenesis: Molecular Mechanisms and Clinical Applications
Xiao Zhang, Lifang Ma, Jiayi Wang
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 7-9, pp. 445-471
Closed Access | Times Cited: 7
Long noncoding RNA SNHG3 interacts with microRNA‐502‐3p to mediate ITGA6 expression in liver hepatocellular carcinoma
Juncheng Guo, Jianquan Zhang, Yang Xiang, et al.
Cancer Science (2024) Vol. 115, Iss. 7, pp. 2286-2300
Open Access | Times Cited: 2
Comprehensive review on lipid metabolism and RNA methylation: Biological mechanisms, perspectives and challenges
Xingyu Wang, Mailin Gan, Yan Wang, et al.
International Journal of Biological Macromolecules (2024) Vol. 270, pp. 132057-132057
Closed Access | Times Cited: 1
The role of RNA modifications in hepatocellular carcinoma: functional mechanism and potential applications
Jin‐Xiu Liu, Xiaoping Zhang, Wenhua Xu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
TRMT10C gene polymorphisms confer hepatoblastoma susceptibility: evidence from a seven-center case-control study
Yanfei Liu, Jinhong Zhu, Xian-Qiang Wang, et al.
Journal of Cancer (2024) Vol. 15, Iss. 16, pp. 5396-5402
Open Access | Times Cited: 1
TRMT61B rs4563180 G>C variant reduces hepatoblastoma risk: a case-control study of seven medical centers
Dingyuan Zeng, Jinhong Zhu, Jingjing Li, et al.
Aging (2023)
Open Access | Times Cited: 3
Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma
Yilin Li, Ke Zhao, Ruike Wu, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 3, pp. 1392-1411
Open Access | Times Cited: 2
Bioinformatics Analysis and Experimental Validation of m3C RNA Methylation Regulators in Hepatocellular Carcinoma
Aqiang Fan, Junchao Lin, Yizhuo Wang, et al.
Research Square (Research Square) (2024)
Open Access
Liver-specific Mettl14 deletion induces nuclear heterotypia and dysregulates RNA export machinery
Keith A. Berggren, Saloni Sinha, Aaron E. Lin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The potential of RNA methylation in the treatment of cardiovascular diseases
Kai Wang, Yuqin Wang, Yinghui Li, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110524-110524
Open Access
Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced technologies
Zixue Xuan, Jian Song, Quanjun Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access
Лауреаты Нобелевской премии по физиологии или медицине 2023 года — Каталин Карико и Дрю Вайсман, "Природа"
Denis N. Antropov, Daria V. Prokhorova, Г. А. Степанов
Priroda (2023), Iss. 12, pp. 64-71
Closed Access
Page 1

Scroll to top